Aducanumab Market Aducanumab received accelerated approval for early-stage Alzheimer’s disease, including mild cognitive impairment (MCI) due to AD and mild AD dementia. The approval was based on its demonstrated ability
Press Release
Aficamten Sales Market Aficamten’s growth is primarily driven by strong unmet need in symptomatic obstructive hypertrophic cardiomyopathy (oHCM), compelling Phase III efficacy data, and its next-generation cardiac myosin inhibition profile.
FYLNETRA Sales FYLNETRA’s growth is driven by accelerating biosimilar adoption in oncology supportive care, payer-led switching from branded pegfilgrastim, and strong formulary inclusion across U.S. hospitals and infusion centers. Coherus’
Core Flooring Center, located in Winter Park, FL, is a premier provider of high-quality flooring solutions. Specializing in hardwood, tile, and vinyl plank flooring, the company combines expert guidance, extensive
Eosinophilic Esophagitis Market Eosinophilic Esophagitis Companies are Ellodi Pharmaceuticals, AstraZeneca, Regeneron Pharmaceuticals, Sanofi, Bristol-Myers Squibb, Allakos, EsoCap AG, Pfizer, Ception
Embolic Protection Devices Market Some of the key market players operating in the embolic protection devices market include Boston Scientific
DelveInsight’s, “Relapsed/refractory acute myeloid leukemia Pipeline Insight 2026” report provides comprehensive insights about 50+ companies and 75+ pipeline drugs in
DelveInsight’s, “Refractory Multiple Myeloma Pipeline Insight 2026” report provides comprehensive insights about 75+ companies and 80+ pipeline drugs in Refractory
DelveInsight’s, “Pulmonary Fibrosis Pipeline Insight 2026” report provides comprehensive insights about 110+ companies and 140+ pipeline drugs in Pulmonary Fibrosis
DelveInsight’s “Psoriasis Pipeline Insight, 2026” report provides comprehensive insights about 65+ companies and 75+ pipeline drugs in the Psoriasis pipeline
